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Introduction
BREAST cancer is the most common cancer and 
an important cause of cancer-related mortality 
among women worldwide (1). The World Health 
Organization (WHO) estimates that by the year 
2020, 70% of newly diagnosed breast cancer cases 
will occur in low- and middle-income countries 
(LMICs) (2). In Uganda, for example, the incidence 
of breast cancer is 32.3 per 100,000, and has increased 
by 5.2% per year over the past 15 years (1).  Many 
Ugandan women with breast cancer are diagnosed 
in their thirties, an age when many are taking care 
of young children and managing their careers and 
households (3). For this and other reasons, breast 
cancer has become a major global health problem 
and has prompted the WHO to intervene (4). 
Low breast cancer awareness and absence of a 
screening program results in detection of 89% of 
all breast cancers in Uganda at later stages (stages 
III and IV) (5). Management of late-stage breast 
cancer is more expensive, technically demanding, 
and results in more morbidity and mortality (M&M) 
than that of early-stage breast cancer (3,5-8). This 
is true even in high-income countries (HIC). Thus, 
early detection is pivotal to cure and reduce M&M, 
irrespective of economical factors.
The term “downstaging” may be used for 
shifting a population with late-stage breast cancers 
to early-stage cancers over a period of time through 
screening, or for an individual case where reduction 
in tumor size (stage) may be affected by neoadjuvant 
chemotherapy before curative surgery. Screening 
may be in the form of breast self-examination (BSE), 
clinical breast examination (CBE), mammography 
or ultrasound. In Uganda, breast cancer treatment 
is free through the Ugandan Cancer Institute (UCI), 
but neoadjuvant chemotherapy is not a viable option 
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in large numbers of patients. Therefore, given the resources, the most 
resource-appropriate strategy seems to be downstaging through 
health awareness leading to increased rates of BSE and CBE. 
According to the Breast Health Global Initiative (BHGI) 
guidelines, resource-appropriate strategies to downstage breast 
cancer in Uganda should include increased breast health awareness, 
so women begin to practice BSE and present early to their providers 
after self-detecting a lump (9, 10). It is also important to train the 
providers in breast health to obtain appropriate history and physical 
examination including a proper CBE. Both BSE and CBE have the 
potential for a high false-positive rate and are, therefore, no longer 
recommended in countries where screening mammography is 
available (11-13). But, with one publically available mammography 
unit in the country, screening mammography is not a feasible option 
for most Ugandan women, particularly rural women. Ultrasound 
is more widely available, even in rural areas, and has the ability to 
characterize palpable masses detected by CBE as those requiring 
biopsy versus those that can safely be managed by imaging or clinical 
follow-up (14). 
In accordance with the World Health Organization’s 
recommendations to reduce the global burden of breast cancer (15), 
Imaging The World (ITW) developed a resource-appropriate strategy 
to downstage breast cancer. ITW is a non-profit organization with a 
global team of volunteers who provide ultrasound training, equipment 
and technology in LMICs to improve and sustain health outcomes 
(16). For this pilot study, we determined the feasibility of this breast 
cancer downstaging strategy in a rural, low-resource setting (Kamuli 
District, Uganda), specifically in terms of: (1) training village health 
teams (VHTs) to provide breast cancer awareness, and (2) training 
sonographers to perform and interpret breast ultrasound. 
Materials and methods
Study team and settings
Imaging the World Africa (ITWA) is a registered non-
governmental organization (NGO) in Uganda, and locally executes 
ITW’s mission with a team of physicians, midwives, sonographers 
and support staff. This pilot project was conducted in the Kamuli 
District, at the Nawanyago Clinic Health Centre III (Nawanyago 
HCIII) and Kamuli Mission Hospital (Referral Hospital), between 
March and August 2013.
Intervention
Study overview
This IRB-approved prospective study evaluated the feasibility of 
the ITW breast cancer downstaging strategy (Figure 1). Women <18 
years, pregnant or acutely ill were excluded. ITW trained VHTs to 
educate women on breast cancer and the importance of presenting 
early after self-detecting a breast lump. Women with a self-detected 
lump presented to Nawanyago HCIII for evaluation, which included 
a CBE by a trained provider. Women with a positive CBE received 
a triaging breast ultrasound by an ITWA-trained sonographer, and 
referred those women with a suspicious mass to the referral hospital 
for further evaluation and potential biopsy by an ITWA-trained 
surgeon. 
Patients receiving a breast cancer diagnosis were referred to the 
UCI for treatment. Patients travelled to the UCI by bus and were met 
at the bus stop in Kampala by an ITWA patient navigator. The UCI 
provided standard-of-care treatment (17) at no cost to the patient, 
and the patient navigator helped arrange necessary medical tests, 
doctor’s appointments, and treatment. 
Breast ultrasound training
ITWA held a three-day workshop and five days of apprenticeship 
to teach a certified sonographer with prior breast imaging experience 
to perform and interpret breast ultrasound (Figure 2) using the 
American College of Radiology (ACR) Breast Imaging Reporting and 
Data System (BI-RADS) (18).
VHT training
ITWA trained VHTs to promote breast cancer awareness at 
events advertised through the local radio and television. VHTs 
educated women at these events on breast cancer and the importance 
of presenting early after self-detecting a lump.
Breast ultrasound imaging equipment and peer review
Ultrasound imaging at the Nawanyago HC III was performed 
on a Philips (Royal Philips, Amsterdam, Netherlands) ClearVue 350 
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Figure 1. Imaging The World 
breast cancer downstaging 
strategy.
with a L12-4 MHz transducer. The sonographer used a standardized 
volumetric scanning protocol performed by sweeping the transducer 
over the entire palpable area, as described previously. Ultrasound 
data was managed via a PACS-compatible electronic medical records 
system, which enabled site data entry and remote database access. An 
American board-certified radiologist reviewed all images remotely 
in the United States and signed off on their interpretations using 
peerVue (peerVue, Inc., Sarastoa, FL, USA), a commercial Web-
based system, for quality assurance. The sonographer communicated 
any changes in the interpretation to the patient. 
Data analysis
For this study, we collected the data at each point of care 
and their outcomes, including contacting women with negative 
and benign results one year after the examination. Performance 
measures for CBE and ultrasound included cancer detection rate 
(CDR; per 1,000 CBEs); abnormal CBE interpretation rate; positive 
predictive value (PPV) 2 (recommendation for tissue diagnosis); 
PPV3 (biopsy performed); sensitivity, specificity, and percent 
minimal cancers, according to the ACR BI-RADS manual, 5th 
edition (18). The percent of women managed locally with BI-RADS 
1, 2, or 3 ultrasound findings that obviated the need for travelling 
to the referral hospital and concordance between the sonographer 
and the American board-certified radiologist were also calculated. 
Calculations were performed using Microsoft Excel (Microsoft 
Corporation, Redmond, WA).
Results
Breast cancer downstaging strategy performance 
The 212 women consenting to participate in this study averaged 
33 years of age. (median: 29 years; range: 17-70). The observed and 
calculated performance of the ITW breast cancer downstaging 
strategy is depicted in Table 1. Forty-four women (21%) presenting 
for evaluation at the Nawanyago HCIII had a positive CBE and 
received a breast ultrasound. Eleven (25%) were interpreted as BI-
RADS 1 or 2, 22 (50%) as BI-RADS 3, and 11 (25%) as BI-RADS 4 or 
5. No breast ultrasound was interpreted as BI-RADS 0 or 6. 
Four women (36%) with a biopsy recommendation (BI-RADS 4 
or 5) traveled to the referral hospital and received a biopsy, and all 
were diagnosed with breast cancer (Figure 3). Of the seven women 
with a biopsy recommendation who did not receive a biopsy, three 
declined, one died prior to biopsy, two converted to BI-RADS 1 after 
antibiotic therapy or lactation ended, and one was lost to follow-up.
The breast cancer detection strategy performed as follows: CDR: 
19 per 1,000 CBEs, abnormal interpretation rate: 21% (44/212), 
PPV2: 36% (4/11), and PPV3: 100% (4/4), sensitivity: 100% (4/4) 
and specificity: 28% (11/40). Ultrasound used as a triage test at the 
Nawanyago HCIII reduced the number of women travelling to the 
referral hospital after a positive CBE by 75% (33/44).
Breast cancer outcomes
Of the four cancers detected during the trial period, two 
represented early-stage and two late-stage breast cancer. Of the two 
women with late-stage breast cancer, one died prior to treatment at 
11 months post-diagnosis, and one died during treatment at nine 
months post-treatment. The two women with early-stage breast 
cancer have completed treatment (chemotherapy, radiation, and 
surgery) at the UCI, are taking Tamoxifen and are being monitored 
for recurrence at the Nawanyago HC III.
Performance of front-line sonographers at Nawanyago 
HCIII
Interpretation by the sonographer at the Nawanyago HCIII 
showed 91% (40/44) concordance with the American board-certified 
radiologist. Three of the discordant examinations upgraded from 
BI-RADS 3 to BI-RADS 4 and one upgraded from BI-RADS 2 to BI-
RADS 3. One of these discordant examinations (upgraded from BI-
RADS 3 to BI-RADS 4) was biopsied and represented breast cancer.
Discussion
Currently, women presenting to the Nawanyago HCIII with 
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Figure 2. Ugandan sonogra-
pher undergoing ultrasound 
training on a breast phantom.
symptoms receive a CBE, and those with a positive CBE are referred 
to a regional hospital located a long distance away for further 
evaluation and potential biopsy. The costs associated with travel 
and time away from work and family responsibilities represent a 
significant barrier to breast cancer detection services. This is partially 
responsible for delayed diagnosis and high mortality (19). For this 
pilot project, we trained certified sonographers with previous breast 
ultrasound experience to perform and interpret breast ultrasound 
using BI-RADS following a positive CBE at the Nawanyago HCIII. 
Using the data from this pilot study, we demonstrate the 
feasibility of the ITW breast cancer downstaging strategy in rural 
Uganda. ITW leveraged existing VHTs to promote breast cancer 
awareness in the community and trained a sonographer with breast 
imaging experience to perform and interpret breast ultrasound 
using BI-RADS at the Nawanyago HCIII. We further demonstrate 
how this strategy reduced by 75 percent the number of women 
travelling to the referral hospital, in many cases long distances, just 
for diagnostic breast ultrasound. Through ITWA’s health awareness 
program and ultrasound we detected breast cancers in stages earlier 
than they would have been detected without our interventions (i.e. 
downstaged).
Shortage of regional referral centers in the country limits patient 
access to centers where women can receive imaging evaluation for 
palpable lumps. Other NGOs in Uganda are involved in training 
sonographers to use basic ultrasound techniques at community 
health centers (HCIIIs) to triage pregnant women with potential 
obstetric complications to district hospitals (20-22). Similarly, 
ITWA’s efforts to train sonographers to characterize breast masses at 
the level of HCIIIs would not only help to downstage breast cancer, 
but also reduce the number of women travelling unnecessarily to 
referral hospitals for nonmalignant breast lumps. 
Aiming to downstage breast cancer using available resources 
represents an essential starting point for interventions addressing 
breast cancer mortality in LMICs. While this pilot study was 
performed to determine feasibility of the ITW strategy, we note 
that two of the four breast cancers (50%) detected by this strategy 
represented early-stage disease, which is lower than the proportion 
of early-stage disease reported in the Ugandan literature (10%) 
Table 1. Performance Measures of Breast Ultrasound.
Variable
Observed Outcomes - Health Center III Number
Screened with CBE 212
Positive CBE 44
Screened with US 44
BR 1 or 2 11
BR 3 22
BR 4 or 5 11
Cancers Diagnosed 4
Performance Measures % (Number)
Cancer Detection Rate (per 1,000 CBE) 19 (4/212)
Abnormal Interpretation Rate (CBE) 21 (44/212)
PPV2 (Recommendation for Biopsy) 36 (4/11)
PPV3 (Biopsy Performed) 100 (4/4)
Sensitivity 100 (4/4)
Specificity 28 (11/40)
Prevented from Referral (BR 1,2,3) 75 (33/44)
% Early Stage Cancer 50% (2/4)
CBE: Clinical Breast Examination
US: Ultrasound
BR: BI-RADS
PPV: Positive Predictive Value 
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Figure 3. Ultrasound images 
of a mass from a woman pre-
senting with a palpable lump 
to Nawanyago HCIII. Biopsy 
of this mass showed breast 
cancer. 
(5). While there is no evidence for improved survival from our 
intervention, both women diagnosed with early-stage breast cancer 
received curative treatment (surgery, chemotherapy, and radiation) 
at the UCI and have returned to their communities. 
CBE performed by ITW-trained providers demonstrated a CDR 
of 19 breast cancers per 1,000 women evaluated. A previous study 
from India showed a CDR of 10.4 per 1,000 women (23). We attribute 
the higher CDR observed in our study to the higher incidence of 
breast cancer in Uganda (32.3 per 100,000) compared to India (20 
per 100,000) and the inclusion of only symptomatic women in our 
study (23,24). We further demonstrate interpretive performance 
for PPV2 and 3 that are within the performance ranges published 
previously (2-96%) (25-28). Our specificity was lower than in these 
studies (49-97%), which reflects the high proportion of women 
presenting with masses assessed as BI-RADS 3 (46%), and also the 
high proportion of young women presenting for evaluation. Since 
BI-RADS 3 masses were followed by ultrasound locally, these women 
did not require travel to the referral hospital for further evaluation. 
The performance of the ITW strategy in this setting highlights the 
success of the ITW training program and suggests that training 
sonographers to perform and interpret breast ultrasound at HCIIIs 
is a resource-appropriate strategy for breast cancer detection in 
Uganda. The sonographer’s 91% concordance rate with an American-
trained radiologist was within the expected inter-observer 
variability observed in other studies (29,30). Future efforts to train 
sonographers to perform and interpret breast ultrasound at HCIIIs 
should improve the telemedicine capacity of Ugandan radiologists 
to provide peer review and ensure sustainability. 
There are several potential limitations of this pilot study. First, 
CBE and BSE as screening strategies are no longer recommended in 
the United States; however, these recommendations do not apply in 
Uganda, where screening mammography is not available. Indeed, 
the National Comprehensive Cancer Network (NCCN) recommends 
BSE because it is essential for women to first detect abnormalities 
in their own breasts before they can present for evaluation (31). 
In addition, seven women recommended for a biopsy did not 
receive one, which may have reduced performance measures. This 
low adherence to biopsy recommendations also emphasizes the 
challenges facing downstaging efforts in Uganda. As this program 
expands, we will add curricula to VHT training programs that will 
address barriers to adhering to biopsy recommendations. 
In summary, we demonstrate the feasibility of the ITW breast 
cancer downstaging strategy in rural Uganda. This strategy combines 
VHTs providing breast cancer awareness in the community to 
encourage women to present early after self-detecting a lump, 
and CBE plus breast ultrasound provided at a HCIII to reduce the 
number of women traveling to the referral hospital. In the future, we 
will expand this program into other districts, in collaboration with 
the Ugandan Ministry of Health and local providers, and collect 
pre-intervention tumor sizes to demonstrate downstaging with this 
strategy.
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